Nebraska Drug Discovery & Development Pipeline

The University of Nebraska's Nebraska Drug Discovery and Development Pipeline (ND3P) is hosting a two-day virtual symposium, featuring plenary lecturers and NU scientists May 30 - 31, 2024.

Attendees will receive information about new tools, insights into novel approaches and introductions to emerging discoveries.

ND3P works to increase the capacity of NU investigators to identify and develop promising new drug targets, leads and candidates to treat human disease in partnership with “expert pharmaceutical consultants.” ND3P also works closely with the National Strategic Research Institute (NSRI) at the University of Nebraska, NU’s DOD-designed University Affiliated Research Center, to identify projects in this space that are of importance to and potentially eligible for funding from the Department of Defense.